Pharmaceuticals
-
Beta-blockers queried for AMI without heart failure
Beta-blockers may be over-prescribed to patients who suffer myocardial infarction, according to British researchers. Read more
-
Chondroitin sulfate "effective" knee treatment
Treatment of knee osteoarthritis with chondroitin sulfate is equally effective as non-steroidal anti-inflammatory drugs, researchers say today. Read more
-
Conference considers diabetes combination therapy
Combination therapy should become more common for type 2 diabetes; a European conference will be told today. Read more
-
Blood tests show antihypertension non-adherence rates
Prescribing multiple anti-hypertensive drugs significantly increases the risk of non-adherence, according to a Manchester based study. Read more
-
Less profitable antibiotics difficult to access
Less profitable antibiotics that are usually prescribed to treat common bacterial infections are becoming increasingly difficult to find, experts warn today. Read more
-
Baclofen could help to treat stuttering
A drug that is being tested for treating treat alcohol dependence could also help to stop stuttering, Dutch doctors report today. Read more
-
Improving HIV therapy normalises life expectancy – study
Anti-retroviral therapy for HIV is so successful that some young patients can expect the same life expectancy as healthy people, according to an analysis published today. Read more
-
Heart risk from popular painkillers
All non-steroidal anti-inflammatory drugs may carry an increased risk of acute myocardial infarction, researchers say today. Read more
-
Predicted rise in drug-resistant TB
Rates of drug-resistant tuberculosis will increase in the four high burden countries – India, the Philippines, Russia, and South Africa – over the next few decades, experts warn today. Read more
-
Phase 3 trial for statins and MS
A phase three trial has been launched to see if statins can successfully treat secondary progressive multiple sclerosis, it has been announced. Read more
